Park Ha Biological Technology Co., Ltd.
BYAH
$1.05
$0.010.96%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.52M | 2.65M | 2.77M | 2.58M | 2.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.52M | 2.65M | 2.77M | 2.58M | 2.38M |
| Cost of Revenue | 142.60K | 149.20K | 155.80K | 175.60K | 195.40K |
| Gross Profit | 2.38M | 2.50M | 2.61M | 2.40M | 2.19M |
| SG&A Expenses | 26.29M | 23.94M | 21.58M | 11.47M | 1.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.67M | 24.23M | 21.78M | 11.69M | 1.59M |
| Operating Income | -24.15M | -21.58M | -19.01M | -9.11M | 793.80K |
| Income Before Tax | -24.08M | -21.52M | -18.96M | -9.08M | 793.40K |
| Income Tax Expenses | 280.80K | 365.10K | 449.40K | 382.10K | 314.80K |
| Earnings from Continuing Operations | -24.36 | -21.89 | -19.41 | -9.46 | 0.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.36M | -21.89M | -19.41M | -9.46M | 478.60K |
| EBIT | -24.15M | -21.58M | -19.01M | -9.11M | 793.80K |
| EBITDA | -24.04M | -21.51M | -18.99M | -9.09M | 816.40K |
| EPS Basic | -43.96 | -40.00 | -36.03 | -17.54 | 0.96 |
| Normalized Basic EPS | -27.17 | -24.57 | -21.97 | -10.49 | 0.99 |
| EPS Diluted | -43.97 | -40.00 | -36.03 | -17.54 | 0.96 |
| Normalized Diluted EPS | -27.17 | -24.57 | -21.97 | -10.49 | 0.99 |
| Average Basic Shares Outstanding | 2.36M | 2.22M | 2.08M | 2.04M | 2.00M |
| Average Diluted Shares Outstanding | 2.36M | 2.22M | 2.08M | 2.04M | 2.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |